Latest news with #MedicalDeviceNetwork
Yahoo
23-05-2025
- Business
- Yahoo
Tariffs to push healthcare facilities to stock up on medical devices
With the surge in tariffs imposed by and on the US, the medical devices industry is likely to be impacted in several areas, including cost, supply chain, and market competitiveness. Healthcare facilities may stock up on medical devices to prepare for increased pricing if they have the budget, says GlobalData, a leading data and analytics company. According to GlobalData's US Healthcare Facility Invoicing Database, across 56 tracked medical device markets, the top 20 facilities as of March 2025 have spent an average of 6.7% more in April. This increase doesn't appear to be attributed to specific markets—across most covered markets, some facilities increased their spend in April, while others decreased their spend. Necessary procedures, such as aspiration thrombectomies, will need to continue being done, whereas elective procedures such as hip reconstruction can be delayed. If prices of devices are driven up by tariffs, hospitals will either face shrinking profit margins or pass on the cost to patients, and patients might not be able to afford the increased procedure costs. The top facilities have already spent more on hip reconstruction devices, with an 18% jump in the average amount spent by facilities from this March to April, compared to a 3% decline last March to April. Similarly, the top facilities are spending more on knee reconstruction devices. From March to April this year, there has been a 9% increase in the average spend, compared to a 13% dip from March to April last year. Looking at aspiration thrombectomy, from March to April 2024, there was a decline of 30% in purchasing. Consistently, the March to April period this year also saw a decline of 30%. This suggests that the top facilities have not been stocking up on aspiration thrombectomy devices despite tariffs. GlobalData expects a continued steady purchasing of devices for necessary procedures, while purchases of devices for elective procedures, such as hip and knee reconstruction, may slow if facilities have already purchased supplies in advance. If tariffs continue, manufacturing sites could move into the US to avoid tariffs for both consumers and manufacturers. Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Tariffs to push healthcare facilities to stock up on medical devices" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
19-05-2025
- Health
- Yahoo
University of Bath develops wearable device for continuous heart monitoring
Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the lungs and heart, providing an alternative to traditional computed tomography (CT) scans. Worn around the chest, the device utilises ultrasound and functions similarly to a CT scanner. It was developed at the university in partnership with Netrix, a Polish technology company. According to the university, this device provides multiple images of the lungs, heart, and other organs over time, unlike a CT scan that captures a single image. This continuous monitoring can give doctors an understanding of a person's condition without needing repeated radiology visits or exposure to ionising radiation. The wearable employs ultrasound computed tomography (USCT) to produce real-time images via a skin-conforming sensor array positioned on the chest of a patient. It has been designed for patient comfort, featuring soft materials that are suitable for prolonged usage and wireless data transmission for integration with hospital systems. The device's usage extends beyond the hospital, with applications in remote monitoring for home care, especially for the elderly or those with chronic cardiopulmonary diseases. It could also help minimise healthcare expenses by eliminating needless hospital admissions through early detection. University of Bath's electronic and electrical engineering professor Manuch Soleimani said: 'This could fundamentally change how we monitor patients in critical care or post-surgical settings. 'The imaging quality of the device can be on par with an X-ray or CT scan, but instead of a single snapshot, we can monitor how the lungs and heart behave over time, which is far more informative when managing dynamic conditions." Clinical trials are in the planning stages to further refine the solution for regulatory clearance. Initial tests on healthy male volunteers have been concluded, with plans to include female participants with conditions such as acute respiratory distress syndrome (ARDS) in future studies. According to the research team, future enhancements may involve adding more ultrasound channels to improve image resolution and adapting the design for brain imaging in emergency settings such as stroke monitoring in ambulances. "University of Bath develops wearable device for continuous heart monitoring" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Health
- Yahoo
Engineers at University of Cincinnati develop cortisol measuring device
Engineers at the University of Cincinnati (UC) in the US have developed a 'lab-on-a-chip' device for measuring the stress hormone cortisol from the saliva of the patient, providing the diagnosis of mental health conditions such as depression and anxiety. Developed by UC professor Chong Ahn and his team, the device is designed to track cortisol levels, as prolonged elevated cortisol is said to be often associated with mental health disorders. UC noted that the system comprises a disposable collection device placed in the patient's mouth for saliva. It is then inserted into a reader that claims to transmit outcomes within minutes to a portable analyser and smartphone. This allows individuals to conduct tests themselves independently and share outcomes with their healthcare providers through their smartphones. Ahn said: 'We're working on point-of-care testing, which allows patients to do testing at home or in a clinic. People don't want to go to a lab to get invasive tests. Mental health care can be an urgent situation. And so these tests will help doctors make timely interventions. 'The system uses traditional psychometric evaluations in a questionnaire along with physiological biomarker measurements that provide evidence-based diagnostics. This approach has the potential to open a new realm of diagnostics for stress disorders.' On the other hand, UC doctoral student Supreeth Setty is expanding on this research by investigating another hormone, dehydroepiandrosterone (DHEA), which balances the effects of cortisol. Setty's findings indicate that high cortisol to DHEA ratios could be markers of chronic stress, with conditions such as anxiety and depression. Moreover, UC researchers noted that their technique can be leveraged for diagnosing other health conditions. They focused on studying the protein troponin, which enters the bloodstream following heart damage from events such as a heart attack. This protein release amount is said to correlate with the extent of damage sustained by the heart. Elevated levels of cardiac troponin, especially when accompanied by symptoms that may suggest an ongoing heart attack, including chest pain. "Engineers at University of Cincinnati develop cortisol measuring device" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Health
- Yahoo
Engineers at University of Cincinnati develop cortisol measuring device
Engineers at the University of Cincinnati (UC) in the US have developed a 'lab-on-a-chip' device for measuring the stress hormone cortisol from the saliva of the patient, providing the diagnosis of mental health conditions such as depression and anxiety. Developed by UC professor Chong Ahn and his team, the device is designed to track cortisol levels, as prolonged elevated cortisol is said to be often associated with mental health disorders. UC noted that the system comprises a disposable collection device placed in the patient's mouth for saliva. It is then inserted into a reader that claims to transmit outcomes within minutes to a portable analyser and smartphone. This allows individuals to conduct tests themselves independently and share outcomes with their healthcare providers through their smartphones. Ahn said: 'We're working on point-of-care testing, which allows patients to do testing at home or in a clinic. People don't want to go to a lab to get invasive tests. Mental health care can be an urgent situation. And so these tests will help doctors make timely interventions. 'The system uses traditional psychometric evaluations in a questionnaire along with physiological biomarker measurements that provide evidence-based diagnostics. This approach has the potential to open a new realm of diagnostics for stress disorders.' On the other hand, UC doctoral student Supreeth Setty is expanding on this research by investigating another hormone, dehydroepiandrosterone (DHEA), which balances the effects of cortisol. Setty's findings indicate that high cortisol to DHEA ratios could be markers of chronic stress, with conditions such as anxiety and depression. Moreover, UC researchers noted that their technique can be leveraged for diagnosing other health conditions. They focused on studying the protein troponin, which enters the bloodstream following heart damage from events such as a heart attack. This protein release amount is said to correlate with the extent of damage sustained by the heart. Elevated levels of cardiac troponin, especially when accompanied by symptoms that may suggest an ongoing heart attack, including chest pain. "Engineers at University of Cincinnati develop cortisol measuring device" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
07-05-2025
- Health
- Yahoo
Endogenex reports results on ReCET system for type 2 diabetes management
Endogenex, a company focused on developing medical devices for type 2 diabetes management, has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San Diego, US. The study evaluated the safety and feasibility of the Endogenex pulsed electric field system (ReCET system) in the US and Australia. The system is an investigational endoscopic outpatient procedure that employs non-thermal energy to address inflamed and dysfunctional tissue linked to type 2 diabetic duodenopathy. This treatment aims to regenerate healthy cells in the mucosal and sub-mucosal layers of the duodenum, which plays a crucial role in metabolic processes. Endogenex CEO Stacey Pugh said: 'The REGENT-1 study continues to deliver promising results, reinforcing the ReCET System's potential as a transformative treatment for type 2 diabetes. 'We have known for some time that the duodenum plays an important role in type 2 diabetes, and these new data– along with other cutting-edge analyses being presented here at DDW – illuminate and reinforce the duodenum as a novel target in the treatment of type 2 diabetes.' The findings from the REGENT-1 Australia study indicated notable enhancements in insulin sensitivity and beta cell function at 12 weeks. Improvements sustained at 48 weeks in a dose-responsive manner, indicating the 'durability' of the treatment, according to the company. The study reported a procedural success rate of 100%, with no serious adverse events related to the device or the procedure, according to the company REGENT-1 study lead author Dr Barham Abu Dayyeh said: 'These findings reinforce that the duodenal mucosa and submucosa are critical therapeutic targets for advancing type 2 diabetes treatment and disease management. 'These results lay the groundwork for further studies, and we are eager to expand the clinical evidence base.' In June 2024, Endogenex closed an oversubscribed Series C financing round, securing $88m to complete the ReCET clinical study. "Endogenex reports results on ReCET system for type 2 diabetes management" was originally created and published by Medical Device Network, a GlobalData owned brand.
